Louise Proulx Ph.D

Louise Proulx Ph.D General Information

Biography

Dr. Proulx holds a Ph.D. in physiology from Universite Laval and pursued postdoctoral studies at the Karolinska Institute in Stockholm. She serves as Chairman at Immune Biosolutions. She has close to 30 years of experience in research and science management. She has held, over the years, scientific positions of increasing responsibilities, notably as Vice President, Scientific Affairs at Hoechst Marion Roussel Canada, Vice President, Therapeutic Product Development at Biochem Pharma Inc., Vice President, Business Development of Genome Quebec and Vice Principal Research at McGill University. She then returned to the pharmaceutical industry where she has been Vice President, Product Development at ViroChem Pharma, Inc. She then became Vice-President, and Site Head, at Vertex Pharmaceuticals (Canada) Incorporated after the acquisition of ViroChem Pharma by Vertex Pharmaceuticals. She is now Chief Development Officer of Therillia Development Company Inc. Dr. Proulx has been a member of several boards of directors over her career and she is currently a member of the board of directors of the Canada Foundation for Innovation, the Research Institute of the McGill University Health Center, Gestion Univalor, Oncozyme Pharma and CQDM. Dr. Proulx is certified ICD.D by the Institute of Corporate Directors.